North America Mycoplasma Testing Market By Product (Kits & Reagents, Instruments And Services), By Technique (PCR, ELSA, Direct Assays, Indirect Assays, Microbial Culture Techniques, Enzymatic Methods, And DNA Staining), By Application (Cell Line Testing, Virus Testing, End-Of-Production Cell Testing And Others), By End User (Pharmaceutical Companies, Contract Research Organizations, Academic Research Institutes And Cell Banks) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)
- Advertising -
The North America mycoplasma testing market was worth USD 148.8 Million in 2016 and is estimated to be growing at a CAGR of 11.5%, to reach USD 256.5 Million by 2021. Mycoplasmas are small bacteria which do not possess a cell wall and they are one of the most prevailing sources of contamination of cell lines.
Mycoplasma contamination is a major hurdle for a cell culturist. They are not visible in normal microscopes and their contamination does not alter pH or turbidity significantly.
- Advertising -
View Full Report at www.marketdataforecast.com/market-…ting-market-3663/
Mycoplasma infections can be very severe. Mycoplasma contamination occurs if already infected culture is brought into the laboratory or a person with human mycoplasma enters the laboratory.
Mycoplasma contamination is a severe problem because they can bring changes in cell culture such as altering cell metabolism, changes in chromosomes of cell culture. Hence, mycoplasma testing is regularly conducted in cell culture research laboratories.
Increase in investments in R&D in the field of life sciences, government organizations funding researchers in drug discovery and development, increase in the number of pharmaceutical and biotechnology industries are some of the major factors driving the growth of mycoplasma testing market in North America. Stringent government regulations and high costs involved with the mycoplasma testing methods are restraining the market growth.
- Kits & Reagent
- Y-o-Y Growth Analysis, By Product
- Market Attractiveness Analysis, By Product
- Market Share Analysis, By Product
- Direct Assays
- Indirect Assays
- Microbial culture techniques
- Enzymatic Methods
- DNA Staining
- Y-o-Y Growth Analysis, By Technique
- Market Attractiveness Analysis, By Technique
- Market Share Analysis, By Technique
- Cell Line Testing
- Virus Testing
- End-Of-Production Cell Testing
- Other Applications
- Y-o-Y Growth Analysis, By Application
- Market Attractiveness Analysis, By Application
- Market Share Analysis, By Application
- Pharmaceutical Companies
- Contract Research Organizations
- Academic Research Institutes
- Cell Banks
- Y-o-Y Growth Analysis, By End User
- Market Attractiveness Analysis, By End User
- Market Share Analysis, By End User
Based on region, North America mycoplasma testing market is segmented into USA and Canada. USA dominates the market in this region with many deep rooted pharmaceutical and biotechnology companies established and increase in cell culture research.
Some of the major companies in the mycoplasma testing market include PromoCell GmbH, Thermo Fisher Scientific Inc., Minerva Biolabs GmbH, Lonza Group Ltd., Charles River Laboratories International, Inc., Gibraltar Laboratories, Sartorius AG, Merck KGaA, Roche Diagnostics, SGS S.A., American Type Culture Collection, InvivoGen, Biological Industries Israel Beit Haemek Ltd., and WuXi AppTec
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: